{"protocolSection": {"identificationModule": {"nctId": "NCT03247829", "orgStudyIdInfo": {"id": "SJM-CIP-10178"}, "organization": {"fullName": "Abbott Medical Devices", "class": "INDUSTRY"}, "briefTitle": "Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS\u2122", "officialTitle": "Investigation to Optimize Hemodynamic Management of HeartMate II\u2122 Left Ventricular Assist Device Patients Using the CardioMEMS\u2122 Pulmonary Artery Pressure Sensor in Advanced Heart Failure", "acronym": "INTELLECT 2-HF"}, "statusModule": {"statusVerifiedDate": "2021-01", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2017-08-24", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2020-03-06", "type": "ACTUAL"}, "completionDateStruct": {"date": "2020-06-30", "type": "ACTUAL"}, "studyFirstSubmitDate": "2017-08-04", "studyFirstSubmitQcDate": "2017-08-08", "studyFirstPostDateStruct": {"date": "2017-08-14", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2022-02-28", "resultsFirstSubmitQcDate": "2023-11-14", "resultsFirstPostDateStruct": {"date": "2024-04-26", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2023-11-14", "lastUpdatePostDateStruct": {"date": "2024-04-26", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Abbott Medical Devices", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "This observational post market study is intended to characterize hemodynamic-guided management of patients with an existing left ventricular assist device (LVAD) to protocol specified target ranges and its impact on functional status, quality of life, and readmissions", "detailedDescription": "The study is an observational, single group study where all participants receive the same intervention. The study plans to enroll up to 100 patients at 25 US sites. All patients will have a HeartMate Left Ventricular Assist Device (LVAD) and a CardioMEMS device implanted as standard of care. After enrollment into the study, the patient will be followed until six month follow up completion. The objective of this clinical investigation is to understand the role of hemodynamic monitoring in LVAD patients and:\n\n* Characterize PA pressure measurements with the CardioMEMS HF System in LVAD patients under different clinical and physiologic conditions\n* Characterize the effects of PA pressure on functional status, quality of life, and hospital readmissions of LVAD patients\n* Evaluate target ranges for PA pressure and assess the impact of medication and pump speed changes on PA pressures"}, "conditionsModule": {"conditions": ["Heart Failure"], "keywords": ["CardioMEMS", "Left Ventricular Assist Device", "Hemodynamic Management"]}, "designModule": {"studyType": "OBSERVATIONAL", "patientRegistry": false, "designInfo": {"observationalModel": "COHORT", "timePerspective": "PROSPECTIVE"}, "enrollmentInfo": {"count": 101, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Group A: Patients with CardioMEMS PA Sensor and HeartMate LVAD prior to study enrollment", "description": "Patients with CardioMEMS PA Sensor and LVAD, previously implanted, will receive hemodynamic management using CardioMEMS HF System", "interventionNames": ["Device: Hemodynamic management using CardioMEMS HF System"]}, {"label": "Group B: Patients with existing HeartMate LVAD implanted with CardioMEMS PA Sensor post enrollment", "description": "Patients with a HeartMate LVAD prior to study enrollment who are implanted with a CardioMEMS PA Sensor within 72 hours of study enrollment, will receive hemodynamic management using CardioMEMS HF System", "interventionNames": ["Device: Hemodynamic management using CardioMEMS HF System"]}], "interventions": [{"type": "DEVICE", "name": "Hemodynamic management using CardioMEMS HF System", "description": "Using the CardioMEMS HF System, clinicians will treat to target PA pressure ranges", "armGroupLabels": ["Group A: Patients with CardioMEMS PA Sensor and HeartMate LVAD prior to study enrollment", "Group B: Patients with existing HeartMate LVAD implanted with CardioMEMS PA Sensor post enrollment"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Six Minute Hall Walk (6MHW) Distance", "description": "Change in 6MHW distance compared to baseline. The six-minute hall walk (6MHW) test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes.", "timeFrame": "Six Months"}], "otherOutcomes": [{"measure": "Change in PA Diastolic Pressure From Baseline to 6 Months", "description": "Changes in PA diastolic pressure measurement over time from baseline to 6 months follow-up.", "timeFrame": "six months"}, {"measure": "Days PA Diastolic Pressure is in the Pre-specified Target Range", "description": "Average number of days PA diastolic pressure was in the pre-specified target range of 8-15 mmHg. For this measure, both arms were combined to assess the mean number of days, all study subjects spent in the target PA diastolic range. This was pre-defined as a whole population analysis.", "timeFrame": "six months"}, {"measure": "PA Diastolic Pressure Before 6MHW Test to After 6MHW Test", "description": "Pulmonary Artery Diastolic Pressure collected using the CardioMEMS-HF system before and after the 6MHW test.", "timeFrame": "6 months"}, {"measure": "Number of Subjects With Either CardioMEMS or HeartMate Device Malfunctions", "description": "Loss of performance, such as inability to submit pressure data for CardioMEMS and/or Pump failure for LVAD. This measure is independent of study arm as both patients had both devices at enrollment. This was pre-defined as a whole population analysis.", "timeFrame": "six months"}, {"measure": "New York Heart Association (NYHA) Classification", "description": "Change in NYHA classification from baseline assessed at 6 months. New York Heart Association (NYHA) Functional Classification stratifies patients' heart failure (HF) by the severity of their symptoms.\n\nI - No limitation of physical activity. II - Slight limitation of physical activity. Comfortable at rest. III - Marked limitation of physical activity. Comfortable at rest. IV - Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.", "timeFrame": "six months"}, {"measure": "EQ-5D-5L VAS", "description": "Health related quality of life (EQ-5D-5L). The EQ-5D-5L self-reported questionnaire includes a visual analog scale (VAS), which records the respondent's self-rated health status on a graduated (0-100) scale, with higher scores for higher quality of life. For this measure, both arms were combined to assess the mean of and changes to the EQ-5D-5L VAS for all study subjects, as all subjects were treated the same and had the same devices once enrolled. This was pre-defined as a whole population analysis.", "timeFrame": "six months"}, {"measure": "Number and Percent of Participants With All-cause Hospitalizations.", "description": "Number and percent of participants who were hospitalized for any cause during follow-up.", "timeFrame": "six months"}, {"measure": "Number and Percent of Participants With Worsening Heart Failure Events", "description": "Worsening HF events incudes emergency department visits, or unscheduled clinic visits for worsening HF, volume management, and/or cardiovascular medication management.", "timeFrame": "six months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Subject has CardioMEMS HF PA Sensor and a commercially-approved HeartMate LVAD (Group A) OR Subject has commercially-approved HeartMate LVAD, is experiencing NYHA class III symptoms, and has had a previous HF hospitalization and meets FDA indications for CardioMEMS. The CardioMEMS PA Sensor must be implanted within 72 hours of consent (Group B)\n2. Signed an informed consent form and agreed to provide access to patient and device data (including CardioMEMS Merlin.net data)\n3. No connectivity or transmission problems with CardioMEMS\n4. On HeartMate LVAD support for at least 3 months\n5. Age \u2265 18 years\n\nExclusion Criteria:\n\n1. Current participation in an investigation that is likely to confound study results or affect study outcome\n2. Current participation in the MOMENTUM3 IDE Clinical trial and has not completed the two year follow-up for that trial\n3. Inability to perform 6MHW test due to conditions other than heart failure (e.g. severe arthritis, orthopedic issues, amputation etc.)", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"], "studyPopulation": "Heart Failure patients will be recruited from the clinicians practice based on the presence of both devices under study", "samplingMethod": "NON_PROBABILITY_SAMPLE"}, "contactsLocationsModule": {"overallOfficials": [{"name": "Kartik Sundareswaran", "affiliation": "Abbott", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Scripps Health", "city": "La Jolla", "state": "California", "zip": "92037", "country": "United States", "geoPoint": {"lat": 32.84727, "lon": -117.2742}}, {"facility": "USC University Hospital", "city": "Los Angeles", "state": "California", "zip": "90033", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "Ronald Reagan UCLA Medical Center", "city": "Los Angeles", "state": "California", "zip": "90095", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "San Diego Cardiac", "city": "San Diego", "state": "California", "zip": "92123", "country": "United States", "geoPoint": {"lat": 32.71533, "lon": -117.15726}}, {"facility": "California Pacific Medical Center - Van Ness Campus", "city": "San Francisco", "state": "California", "zip": "94109", "country": "United States", "geoPoint": {"lat": 37.77493, "lon": -122.41942}}, {"facility": "University of Kentucky", "city": "Lexington", "state": "Kentucky", "zip": "40536", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"facility": "University of Michigan", "city": "Ann Arbor", "state": "Michigan", "zip": "48109", "country": "United States", "geoPoint": {"lat": 42.27756, "lon": -83.74088}}, {"facility": "University of Minnesota", "city": "Minneapolis", "state": "Minnesota", "zip": "55455", "country": "United States", "geoPoint": {"lat": 44.97997, "lon": -93.26384}}, {"facility": "The Nebraska Medical Center", "city": "Omaha", "state": "Nebraska", "zip": "68105", "country": "United States", "geoPoint": {"lat": 41.25626, "lon": -95.94043}}, {"facility": "North Shore University Hospital", "city": "Manhasset", "state": "New York", "zip": "11030", "country": "United States", "geoPoint": {"lat": 40.79788, "lon": -73.69957}}, {"facility": "New York-Presbyterian/Columbia University Medical Center", "city": "New York", "state": "New York", "zip": "10032", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "University of Rochester Medical Center", "city": "Rochester", "state": "New York", "zip": "14642", "country": "United States", "geoPoint": {"lat": 43.15478, "lon": -77.61556}}, {"facility": "St. Francis Hospital", "city": "Roslyn", "state": "New York", "zip": "11576", "country": "United States", "geoPoint": {"lat": 40.79982, "lon": -73.65096}}, {"facility": "University of North Carolina at Chapel Hill", "city": "Chapel Hill", "state": "North Carolina", "zip": "27607", "country": "United States", "geoPoint": {"lat": 35.9132, "lon": -79.05584}}, {"facility": "University of North Carolina", "city": "Raleigh", "state": "North Carolina", "zip": "27607", "country": "United States", "geoPoint": {"lat": 35.7721, "lon": -78.63861}}, {"facility": "University Hospitals Cleveland Medical Center", "city": "Cleveland", "state": "Ohio", "zip": "44106", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "The Cleveland Clinic Foundation", "city": "Cleveland", "state": "Ohio", "zip": "44195", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "Ohio Sate University", "city": "Columbus", "state": "Ohio", "zip": "43210", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "Providence Heart and Vascular Institute", "city": "Portland", "state": "Oregon", "zip": "97225", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"facility": "Palmetto Health Richland", "city": "Columbia", "state": "South Carolina", "zip": "29203", "country": "United States", "geoPoint": {"lat": 34.00071, "lon": -81.03481}}, {"facility": "The Methodist Hospital", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "University of Utah Hospital", "city": "Salt Lake City", "state": "Utah", "zip": "84132", "country": "United States", "geoPoint": {"lat": 40.76078, "lon": -111.89105}}, {"facility": "Aurora Medical Center", "city": "Milwaukee", "state": "Wisconsin", "zip": "53215", "country": "United States", "geoPoint": {"lat": 43.0389, "lon": -87.90647}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "The study enrolled a total of 101 subjects at 22 investigational sites in the United States. The first subject was enrolled on 24 August 2017 and enrollment was completed on 20 August 2019. The last 6-month follow-up was completed on 6 March 2020. Data was collected until the database closure date, 3 April 2020.", "groups": [{"id": "FG000", "title": "Group A", "description": "Patients with both a CardioMEMS PA Sensor and HeartMate II or HeartMate 3 Left Ventricular Assist Device (LVAD) previously implanted, will receive hemodynamic management guided using hemodynamic data as measured by the CardioMEMS HF System"}, {"id": "FG001", "title": "Group B", "description": "Patients with a HeartMate II or HeartMate 3 LVAD previously implanted who are implanted with a CardioMEMS PA Sensor within 72 hours of enrollment, will receive hemodynamic management guided using hemodynamic data as measured by the CardioMEMS HF System."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "53"}, {"groupId": "FG001", "numSubjects": "48"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "46"}, {"groupId": "FG001", "numSubjects": "42"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "6"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "4"}]}, {"type": "Enter Hospice Care", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "LVAD System Replaced / Exchange", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "LVAD Explant", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Transplant", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Group A", "description": "Patients with CardioMEMS and LVAD, previously implanted, will receive hemodynamic management using CardioMEMS\n\nHemodynamic management using CardioMEMS: Using the CardioMEMS HF system, clinicians will treat to target PA pressure ranges"}, {"id": "BG001", "title": "Group B", "description": "Patients with LVAD to implant CardioMEMS device within 72 hours of enrollment, will receive hemodynamic management using CardioMEMS\n\nHemodynamic management using CardioMEMS: Using the CardioMEMS HF system, clinicians will treat to target PA pressure ranges."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "101"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "101"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "62.4", "spread": "11.4"}, {"groupId": "BG001", "value": "59.9", "spread": "13.6"}, {"groupId": "BG002", "value": "61.2", "spread": "12.5"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "101"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "11"}, {"groupId": "BG002", "value": "25"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "39"}, {"groupId": "BG001", "value": "37"}, {"groupId": "BG002", "value": "76"}]}]}]}, {"title": "Race and Ethnicity Not Collected", "populationDescription": "Race and Ethnicity were not collected from any participant.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}], "categories": [{"measurements": [{"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "101"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "101"}]}]}]}, {"title": "Ischemic Cardiomyopathy", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "101"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "25"}, {"groupId": "BG001", "value": "22"}, {"groupId": "BG002", "value": "47"}]}]}]}, {"title": "Body Mass Index (BMI)", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "kg/m^2", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "101"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "32.31", "spread": "7.78"}, {"groupId": "BG001", "value": "34.08", "spread": "7.52"}, {"groupId": "BG002", "value": "33.15", "spread": "7.67"}]}]}]}, {"title": "Systemic Systolic Pressure", "populationDescription": "Systemic Systolic Pressure was not acquired from all patients at baseline.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mmHg", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "19"}, {"groupId": "BG001", "value": "23"}, {"groupId": "BG002", "value": "42"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "100.6", "spread": "30.4"}, {"groupId": "BG001", "value": "105.7", "spread": "14.9"}, {"groupId": "BG002", "value": "103.4", "spread": "23.1"}]}]}]}, {"title": "Systemic Diastolic Pressure", "populationDescription": "Systemic Diastolic Pressure was not acquired from all patients at baseline.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mmHg", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "18"}, {"groupId": "BG001", "value": "23"}, {"groupId": "BG002", "value": "41"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "64.7", "spread": "26.6"}, {"groupId": "BG001", "value": "72.6", "spread": "20.3"}, {"groupId": "BG002", "value": "69.1", "spread": "23.3"}]}]}]}, {"title": "Heart Rate", "populationDescription": "Heart Rate was not acquired from all patients at baseline.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "beats per minute", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "52"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "100"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "79.2", "spread": "17.8"}, {"groupId": "BG001", "value": "78.6", "spread": "16.1"}, {"groupId": "BG002", "value": "78.9", "spread": "16.9"}]}]}]}, {"title": "NYHA Functional Class", "description": "New York Heart Association (NYHA) Functional Classification stratifies patients' heart failure (HF) by the severity of their symptoms.\n\nI - No limitation of physical activity. II - Slight limitation of physical activity. Comfortable at rest. III - Marked limitation of physical activity. Comfortable at rest. IV - Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "NYHA Class I", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "101"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "2"}]}]}, {"title": "NYHA Class II", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "101"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "19"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "25"}]}]}, {"title": "NYHA Class III", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "101"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "28"}, {"groupId": "BG001", "value": "42"}, {"groupId": "BG002", "value": "70"}]}]}, {"title": "NYHA Class IV", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "101"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "4"}]}]}]}, {"title": "Six Minute Walk Distance", "populationDescription": "Six Minute Hall Walk was not acquired from all patients at baseline.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "meters", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "45"}, {"groupId": "BG002", "value": "98"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "252.08", "spread": "136.17"}, {"groupId": "BG001", "value": "243.76", "spread": "109.58"}, {"groupId": "BG002", "value": "248.26", "spread": "124.11"}]}]}]}, {"title": "EQ-5D-5L VAS", "description": "The EQ-5D-5L self-reported questionnaire includes a visual analog scale (VAS), which records the respondent's self-rated health status on a graduated (0-100) scale, with higher scores for higher quality of life.", "populationDescription": "EQ-5D-5L VAS test was not obtained from all patients at baseline.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "score on a scale", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "46"}, {"groupId": "BG002", "value": "99"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "70.3", "spread": "19.1"}, {"groupId": "BG001", "value": "66.2", "spread": "20.6"}, {"groupId": "BG002", "value": "68.4", "spread": "19.8"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Six Minute Hall Walk (6MHW) Distance", "description": "Change in 6MHW distance compared to baseline. The six-minute hall walk (6MHW) test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes.", "populationDescription": "Six minute hall walk distance measured at 6 months compared to baseline.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "Six Months", "groups": [{"id": "OG000", "title": "Group A", "description": "Group A: Patients with CardioMEMS PA Sensor and HeartMate LVAD prior to study enrollment.\n\nPatients with CardioMEMS PA Sensor and LVAD, previously implanted, received hemodynamic management using CardioMEMS HF System."}, {"id": "OG001", "title": "Group B", "description": "Group B: Patients with existing HeartMate LVAD at enrollment who were implanted with CardioMEMS PA Sensor post enrollment.\n\nPatients with a HeartMate LVAD prior to study enrollment who are implanted with a CardioMEMS PA Sensor within 72 hours of study enrollment, received hemodynamic management using CardioMEMS HF System."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "46"}, {"groupId": "OG001", "value": "42"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-44.9", "spread": "135.0"}, {"groupId": "OG001", "value": "69.7", "spread": "100.6"}]}]}], "analyses": [{"groupIds": ["OG001"], "nonInferiorityType": "OTHER", "pValue": "0.001", "statisticalMethod": "t-test, 2 sided", "statisticalComment": "Comparative p-values were calculated by two-sided t-tests (paired analysis)."}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change in PA Diastolic Pressure From Baseline to 6 Months", "description": "Changes in PA diastolic pressure measurement over time from baseline to 6 months follow-up.", "populationDescription": "Change in PA Diastolic pressure from baseline to 6 months.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "six months", "groups": [{"id": "OG000", "title": "Group A", "description": "Group A: Patients with CardioMEMS PA Sensor and HeartMate LVAD prior to study enrollment.\n\nPatients with CardioMEMS PA Sensor and LVAD, previously implanted, received hemodynamic management using CardioMEMS HF System."}, {"id": "OG001", "title": "Group B", "description": "Group B: Patients with existing HeartMate LVAD at enrollment who were implanted with CardioMEMS PA Sensor post enrollment.\n\nPatients with a HeartMate LVAD prior to study enrollment who are implanted with a CardioMEMS PA Sensor within 72 hours of study enrollment, received hemodynamic management using CardioMEMS HF System."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "37"}, {"groupId": "OG001", "value": "33"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.6", "spread": "4.2"}, {"groupId": "OG001", "value": "-1.7", "spread": "5.6"}]}]}], "analyses": [{"groupIds": ["OG001"], "nonInferiorityType": "OTHER", "pValue": "0.0931", "statisticalMethod": "t-test, 2 sided"}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Days PA Diastolic Pressure is in the Pre-specified Target Range", "description": "Average number of days PA diastolic pressure was in the pre-specified target range of 8-15 mmHg. For this measure, both arms were combined to assess the mean number of days, all study subjects spent in the target PA diastolic range. This was pre-defined as a whole population analysis.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "days", "timeFrame": "six months", "groups": [{"id": "OG000", "title": "All Patients", "description": "All patients enrolled in the study.\n\nHemodynamic management using CardioMEMS: Using the CardioMEMS HF system, clinicians will treat to target PA pressure ranges"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "101"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "28.2", "spread": "39.0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "PA Diastolic Pressure Before 6MHW Test to After 6MHW Test", "description": "Pulmonary Artery Diastolic Pressure collected using the CardioMEMS-HF system before and after the 6MHW test.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "Group A Pre 6MHW Test", "description": "Group A: Patients with CardioMEMS PA Sensor and HeartMate LVAD prior to study enrollment.\n\nPatients with CardioMEMS PA Sensor and LVAD, previously implanted, received hemodynamic management using CardioMEMS HF System."}, {"id": "OG001", "title": "Group A Post 6MHW Test", "description": "Group A: Patients with CardioMEMS PA Sensor and HeartMate LVAD prior to study enrollment.\n\nPatients with CardioMEMS PA Sensor and LVAD, previously implanted, received hemodynamic management using CardioMEMS HF System."}, {"id": "OG002", "title": "Group B Pre 6MHW Test", "description": "Group B: Patients with existing HeartMate LVAD at enrollment who were implanted with CardioMEMS PA Sensor post enrollment.\n\nPatients with a HeartMate LVAD prior to study enrollment who are implanted with a CardioMEMS PA Sensor within 72 hours of study enrollment, received hemodynamic management using CardioMEMS HF System."}, {"id": "OG003", "title": "Group B Post 6MHW Test", "description": "Group B: Patients with existing HeartMate LVAD at enrollment who were implanted with CardioMEMS PA Sensor post enrollment.\n\nPatients with a HeartMate LVAD prior to study enrollment who are implanted with a CardioMEMS PA Sensor within 72 hours of study enrollment, received hemodynamic management using CardioMEMS HF System."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "44"}, {"groupId": "OG001", "value": "39"}, {"groupId": "OG002", "value": "38"}, {"groupId": "OG003", "value": "35"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "13.9", "spread": "7.2"}, {"groupId": "OG001", "value": "16.3", "spread": "6.8"}, {"groupId": "OG002", "value": "15.8", "spread": "8.2"}, {"groupId": "OG003", "value": "19.8", "spread": "10.6"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Subjects With Either CardioMEMS or HeartMate Device Malfunctions", "description": "Loss of performance, such as inability to submit pressure data for CardioMEMS and/or Pump failure for LVAD. This measure is independent of study arm as both patients had both devices at enrollment. This was pre-defined as a whole population analysis.", "populationDescription": "All patients with LVAD and CardioMEMS device in place.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "six months", "groups": [{"id": "OG000", "title": "All Patients", "description": "All patients with an LVAD and CardioMEMS device in place."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "101"}]}], "classes": [{"categories": [{"title": "No Device Malfunction (HM II & HM3)", "measurements": [{"groupId": "OG000", "value": "99"}]}, {"title": "Pump thrombosis (HM II)", "measurements": [{"groupId": "OG000", "value": "1"}]}, {"title": "Driveline fracture (HM II)", "measurements": [{"groupId": "OG000", "value": "1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "New York Heart Association (NYHA) Classification", "description": "Change in NYHA classification from baseline assessed at 6 months. New York Heart Association (NYHA) Functional Classification stratifies patients' heart failure (HF) by the severity of their symptoms.\n\nI - No limitation of physical activity. II - Slight limitation of physical activity. Comfortable at rest. III - Marked limitation of physical activity. Comfortable at rest. IV - Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.", "populationDescription": "NYHA class as a continuous variable in which the change in NYHA class is calculated using: NYHA class I =1, class II = 2, class IIIa/IIIb = 3, class IV = 4 and death =5.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Change in NYHA Class", "timeFrame": "six months", "groups": [{"id": "OG000", "title": "Group A", "description": "Group A: Patients with CardioMEMS PA Sensor and HeartMate LVAD prior to study enrollment.\n\nPatients with CardioMEMS PA Sensor and LVAD, previously implanted, received hemodynamic management using CardioMEMS HF System."}, {"id": "OG001", "title": "Group B", "description": "Group B: Patients with existing HeartMate LVAD at enrollment who were implanted with CardioMEMS PA Sensor post enrollment.\n\nPatients with a HeartMate LVAD prior to study enrollment who are implanted with a CardioMEMS PA Sensor within 72 hours of study enrollment, received hemodynamic management using CardioMEMS HF System."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "53"}, {"groupId": "OG001", "value": "48"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.12", "lowerLimit": "-0.11", "upperLimit": "0.35"}, {"groupId": "OG001", "value": "-0.10", "lowerLimit": "-0.32", "upperLimit": "0.11"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "EQ-5D-5L VAS", "description": "Health related quality of life (EQ-5D-5L). The EQ-5D-5L self-reported questionnaire includes a visual analog scale (VAS), which records the respondent's self-rated health status on a graduated (0-100) scale, with higher scores for higher quality of life. For this measure, both arms were combined to assess the mean of and changes to the EQ-5D-5L VAS for all study subjects, as all subjects were treated the same and had the same devices once enrolled. This was pre-defined as a whole population analysis.", "populationDescription": "Change in EQ-5D-5L VAS scores from baseline to 6 months.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Change in score", "timeFrame": "six months", "groups": [{"id": "OG000", "title": "Group A", "description": "Group A: Patients with CardioMEMS PA Sensor and HeartMate LVAD prior to study enrollment.\n\nPatients with CardioMEMS PA Sensor and LVAD, previously implanted, received hemodynamic management using CardioMEMS HF System."}, {"id": "OG001", "title": "Group B", "description": "Group B: Patients with existing HeartMate LVAD at enrollment who were implanted with CardioMEMS PA Sensor post enrollment.\n\nPatients with a HeartMate LVAD prior to study enrollment who are implanted with a CardioMEMS PA Sensor within 72 hours of study enrollment, received hemodynamic management using CardioMEMS HF System."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "53"}, {"groupId": "OG001", "value": "48"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-1.4", "lowerLimit": "-7.7", "upperLimit": "4.9"}, {"groupId": "OG001", "value": "3.0", "lowerLimit": "-3.2", "upperLimit": "9.1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number and Percent of Participants With All-cause Hospitalizations.", "description": "Number and percent of participants who were hospitalized for any cause during follow-up.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "six months", "groups": [{"id": "OG000", "title": "Group A", "description": "Group A: Patients with CardioMEMS PA Sensor and HeartMate LVAD prior to study enrollment.\n\nPatients with CardioMEMS PA Sensor and LVAD, previously implanted, received hemodynamic management using CardioMEMS HF System."}, {"id": "OG001", "title": "Group B", "description": "Group B: Patients with existing HeartMate LVAD at enrollment who were implanted with CardioMEMS PA Sensor post enrollment.\n\nPatients with a HeartMate LVAD prior to study enrollment who are implanted with a CardioMEMS PA Sensor within 72 hours of study enrollment, received hemodynamic management using CardioMEMS HF System."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "53"}, {"groupId": "OG001", "value": "48"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "27"}, {"groupId": "OG001", "value": "25"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number and Percent of Participants With Worsening Heart Failure Events", "description": "Worsening HF events incudes emergency department visits, or unscheduled clinic visits for worsening HF, volume management, and/or cardiovascular medication management.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "six months", "groups": [{"id": "OG000", "title": "Group A", "description": "Group A: Patients with CardioMEMS PA Sensor and HeartMate LVAD prior to study enrollment.\n\nPatients with CardioMEMS PA Sensor and LVAD, previously implanted, received hemodynamic management using CardioMEMS HF System."}, {"id": "OG001", "title": "Group B", "description": "Group B: Patients with existing HeartMate LVAD at enrollment who were implanted with CardioMEMS PA Sensor post enrollment.\n\nPatients with a HeartMate LVAD prior to study enrollment who are implanted with a CardioMEMS PA Sensor within 72 hours of study enrollment, received hemodynamic management using CardioMEMS HF System."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "53"}, {"groupId": "OG001", "value": "48"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "14"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "6 months", "eventGroups": [{"id": "EG000", "title": "All Patients", "description": "Patients with both an LVAD and CardioMEMS device in place. All safety assessments were made on a population basis, as all subjects were treated the same and had the same devices once enrolled. This was pre-defined as a whole population analysis.", "deathsNumAffected": 7, "deathsNumAtRisk": 101, "seriousNumAffected": 36, "seriousNumAtRisk": 101, "otherNumAffected": 3, "otherNumAtRisk": 101}], "seriousEvents": [{"term": "Worsening Heart Failure", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Worsening Heart Failure", "stats": [{"groupId": "EG000", "numEvents": 23, "numAffected": 20, "numAtRisk": 101}]}, {"term": "Syncope/presyncope/dizziness and hypovolemia", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Syncope/presyncope/dizziness and hypovolemia", "stats": [{"groupId": "EG000", "numEvents": 14, "numAffected": 11, "numAtRisk": 101}]}, {"term": "Cardiac arrhythmias", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Cardiac arrhythmias", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 101}]}, {"term": "Right heart failure", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Right heart failure", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 101}]}, {"term": "Renal dysfunction secondary to heart failure", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Renal dysfunction secondary to heart failure", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 101}]}, {"term": "Other neurological event", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Other neurological event", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 101}]}, {"term": "Respiratory failure secondary to cardiovascular cause", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Respiratory failure secondary to cardiovascular cause", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 101}]}, {"term": "Strokes regardless of their type and etiology", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Strokes regardless of their type and etiology", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 101}]}, {"term": "Other", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Other", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 4, "numAtRisk": 101}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Pneumonia", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 101}]}, {"term": "Hypotension", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Hypotension", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 101}]}, {"term": "Over-diuresis", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Over-diuresis", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 101}]}, {"term": "Volume Overload", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Volume Overload", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 101}]}], "otherEvents": [{"term": "Non-serious Adverse Device Effects", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events were classified by organ class only for non-serious adverse device effects.", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 101}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "No limitations or caveats to disclose for this study."}, "certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": true}, "pointOfContact": {"title": "Dr. Marie-Elena Brett, PhD; Principal Scientist Clinical Research", "organization": "Abbott_Medical_Devices", "email": "marieelena.brett@abbott.com", "phone": "17815283613"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP_ICF", "hasProtocol": true, "hasSap": true, "hasIcf": true, "label": "Study Protocol, Statistical Analysis Plan, and Informed Consent Form", "date": "2018-06-18", "uploadDate": "2021-02-12T19:59", "filename": "Prot_SAP_ICF_000.pdf", "size": 1694351}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}